Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Article

AJVS. 2018; 59(1): 143-148

Adverse Drug Events in Puppies Following Treatment with Amoxicillin with or without Clavulanate

Fidelis A. Gberindyer, Felix K. Shima, Oladipo O. Omotosho, Temidayo O. Omobowale, Matthew O. Abatan.

This study reports adverse drug events (ADEs) in puppies following treatment with amoxicillin with or without clavulanate. A prospective and observational multicentre study was conducted in five Veterinary clinics in Nigeria where 63 heterogeneous puppies with parvovirus enteritis were used. Puppies in group A (n=36) were treated with amoxicillin alone (n=16), or with clavulanate (n=20) by IV route, whereas group B (n=27) were administered amoxicillin alone by IM route. All puppies were administered a single dose of 15mg/kg, thereafter, observed for ADEs within 3 hours. Those that manifested ADEs were subsequently administered 2mg/kg IV single dose of diphenhydramine. Out of 63 puppies, 12(18.5%) had diarrhoea, hyper-salivation, cutaneous erythema, and swellings around eyelids and buccal areas within 5 minutes post-treatments. These were observed only in puppies treated by IV route, where 5/16(31.3%) of those administered amoxicillin with clavulanate, and 7/20(35%) of those treated with amoxicillin alone showed these signs, which resolved following diphenhydramine administration. No ADEs were observed after subsequent treatment of the affected puppies with amoxicillin alone by IM route. Although amoxicillin is usually well tolerated, this study recommends that veterinarians should be cautious when it becomes neccessary to treat dogs with amoxicillin alone or with clavulanate by IV route to circumvent these ADEs.

Key words: Adverse drug events, allergy, amoxicillin, diphenhydramine, puppies, intravenous route

Share this Article

Journal of Molecular Pathophysiology


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.